The role of interleukin-17 in covid-19

N. Ya. Fayzullaeva^a*, I. A. Akramova^b, B. M. Tadjiev^b, L.G. Sabirzyanova^a, U.P. Nabieva^a

ABSTRACT: According to WHO recommendations, COVID-19 is a disease caused by a new coronavirus called SARS-CoV-2. WHO first became aware of this novel virus on 31 December 2019 when a cluster of "viral pneumonia" cases was reported in Wuhan, China. The most common symptoms of COVID-19 include fever, dry cough, fatigue, loss of smell or taste, nasal congestion, conjunctivitis (or redness of the eyes), sore throat, headache, and other unspecific symptoms. In this article, we analyze the role of interleukin-17 in COVID-19.

Download PDF

50 Downloads 144 Views

^a	Institute of immunology and human genomics of academy of sciences of Uzbekistan, Tashkent, Uzbekistan
^b	Republican specialized scientific and practical medical center of epidemiology, microbiology, infectious and parasitic diseases , Tashkent, Uzbekistan

* Corresponding author, E-mail:

Received 15 Aug 2022, Accepted 10 Nov 2022

The role of interleukin-17 in covid-19

N. Ya. Fayzullaevaa*, I. A. Akramovab, B. M. Tadjievb, L.G. Sabirzyanovaa, U.P. Nabievaa

N. Ya. Fayzullaeva^a*, I. A. Akramova^b, B. M. Tadjiev^b, L.G. Sabirzyanova^a, U.P. Nabieva^a